These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 6152205

  • 21. Sulphasalazine in rheumatoid arthritis.
    Crisp AJ.
    Br J Rheumatol; 1984 Aug; 23(3):232. PubMed ID: 6146376
    [No Abstract] [Full Text] [Related]

  • 22. Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challenge.
    van Riel PL, van de Putte LB.
    Neth J Med; 1990 Jun; 36(5-6):221-2. PubMed ID: 1975649
    [No Abstract] [Full Text] [Related]

  • 23. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Farr M, Bacon PA.
    Ann Rheum Dis; 1987 May; 46(5):421. PubMed ID: 2884936
    [No Abstract] [Full Text] [Related]

  • 24. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
    Winkler V.
    Orv Hetil; 1986 Aug 24; 127(34):2073-4, 2079-80. PubMed ID: 2876405
    [No Abstract] [Full Text] [Related]

  • 25. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
    Greaves M, Amos RS, Bax D.
    Br Med J (Clin Res Ed); 1987 Feb 07; 294(6568):373. PubMed ID: 2880620
    [No Abstract] [Full Text] [Related]

  • 26. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
    Prouse PJ, Shawe D, Gumpel JM.
    Br Med J (Clin Res Ed); 1986 Nov 29; 293(6559):1407. PubMed ID: 2879599
    [No Abstract] [Full Text] [Related]

  • 27. Ten years of sulphasalazine use in rheumatoid arthritis.
    McConkey B.
    Br J Rheumatol; 1989 Apr 29; 28(2):175-6. PubMed ID: 2565130
    [No Abstract] [Full Text] [Related]

  • 28. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT, Myklebust G.
    Scand J Rheumatol; 1993 Apr 29; 22(5):229-32. PubMed ID: 7901898
    [Abstract] [Full Text] [Related]

  • 29. Sulphasalazine in rheumatoid arthritis.
    Pullar T, Hunter JA, Capell HA.
    Lancet; 1985 May 18; 1(8438):1167. PubMed ID: 2860375
    [No Abstract] [Full Text] [Related]

  • 30. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
    Delamere JP, Farr M, Grindulis KA.
    Br Med J (Clin Res Ed); 1983 May 14; 286(6377):1547-8. PubMed ID: 6133577
    [No Abstract] [Full Text] [Related]

  • 31. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
    Murphy PT, O'Donnell JR.
    Ir J Med Sci; 1990 Jun 14; 159(6):195. PubMed ID: 1977725
    [No Abstract] [Full Text] [Related]

  • 32. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS, Pullar T, Bax DE, Situnayake D, Capell HA, McConkey B.
    Br Med J (Clin Res Ed); 1986 Aug 16; 293(6544):420-3. PubMed ID: 2874863
    [Abstract] [Full Text] [Related]

  • 33. Sulphasalazine in rheumatoid arthritis: an old drug revived.
    Neumann VC, Grindulis KA.
    J R Soc Med; 1984 Mar 16; 77(3):169-72. PubMed ID: 6142116
    [No Abstract] [Full Text] [Related]

  • 34. Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.
    Farr M, Tunn E, Bacon PA, Smith DH.
    Ann Rheum Dis; 1985 Oct 16; 44(10):723-4. PubMed ID: 2864899
    [No Abstract] [Full Text] [Related]

  • 35. [Pulmonary toxicity of gold salts].
    Fernández Casares M, Casas HA, Leczycki H.
    Medicina (B Aires); 1991 Oct 16; 51(1):59-61. PubMed ID: 1669957
    [Abstract] [Full Text] [Related]

  • 36. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S.
    Lancet; 1997 Aug 02; 350(9074):309-18. PubMed ID: 9251634
    [Abstract] [Full Text] [Related]

  • 37. Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.
    MacGilchrist AJ, Hunter JA.
    Ann Rheum Dis; 1986 Nov 02; 45(11):967-8. PubMed ID: 2878646
    [No Abstract] [Full Text] [Related]

  • 38. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M, Madhok R, Capell HA, Hunter JA.
    Ann Rheum Dis; 1989 Jun 02; 48(6):505-7. PubMed ID: 2568110
    [Abstract] [Full Text] [Related]

  • 39. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A, Pedone V, Lamanna G, Cervini C.
    Clin Ter; 1997 Jun 02; 148(1-2):7-13. PubMed ID: 9377840
    [Abstract] [Full Text] [Related]

  • 40. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z, Vácha J, Trnavský K.
    Z Rheumatol; 1985 Jun 02; 44(6):263-6. PubMed ID: 2869625
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.